Table 12 Antimicrobial activity of compounds a25 and a26
From: Therapeutic potential of heterocyclic pyrimidine scaffolds
Compounds | Microbial strains (µg/ml) | |||||
|---|---|---|---|---|---|---|
E. coli | P. aeruginosa | S. aureus | S. pyogenus | C. albicans | A. niger | |
a25 | 62.5 | 200 | 100 | 100 | 200 | 250 |
a26 | 25 | 50 | 100 | 50 | 500 | 250 |
Chloramphenicol | 50 | 50 | 50 | 50 | – | – |
Ciprofloxacin | 25 | 25 | 50 | 50 | – | – |
Norfloxacin | 10 | 10 | 10 | 10 | – | – |
Nystatin | Â | Â | Â | Â | 100 | 100 |